These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19616807)

  • 1. Combination drug therapy improves compliance of the neurogenic bladder.
    Cameron AP; Clemens JQ; Latini JM; McGuire EJ
    J Urol; 2009 Sep; 182(3):1062-7. PubMed ID: 19616807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J; Kramer G; Jakse G
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects.
    Amend B; Hennenlotter J; Schäfer T; Horstmann M; Stenzl A; Sievert KD
    Eur Urol; 2008 May; 53(5):1021-8. PubMed ID: 18243516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case series data to encourage randomized trials of bladder retraining compared to antimuscarinic agents.
    Ghei M; Miller R; Malone-Lee J
    J Urol; 2006 Apr; 175(4):1411-5; discussion 1415-6. PubMed ID: 16516010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
    Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ; Lemack GE; Foote JE; Trop CS
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of tolterodine and patient compliance in pediatric patients with neurogenic detrusor overactivity.
    Christoph F; Moschkowitsch A; Kempkensteffen C; Schostak M; Miller K; Schrader M
    Urol Int; 2007; 79(1):55-9. PubMed ID: 17627170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
    JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
    Fader M; Glickman S; Haggar V; Barton R; Brooks R; Malone-Lee J
    J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nitric oxide donors: a new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients?
    Reitz A; Knapp PA; Müntener M; Schurch B
    Eur Urol; 2004 Apr; 45(4):516-20. PubMed ID: 15041118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report.
    Neel KF; Salem M; Soliman S
    J Pediatr Urol; 2008 Apr; 4(2):124-6. PubMed ID: 18631907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence with antimuscarinic therapy in patients with overactive bladder.
    Haab F; Castro-Diaz D
    Int J Clin Pract; 2005 Aug; 59(8):931-7. PubMed ID: 16033615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic bladder dysfunction after sacrococcygeal teratoma resection.
    Ozkan KU; Bauer SB; Khoshbin S; Borer JG
    J Urol; 2006 Jan; 175(1):292-6; discussion 296. PubMed ID: 16406929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies of the uninhibited neurogenic bladder. III. The influence of adrenergic excitatory and inhibitory drugs on the cystometrogram of neurological patients with normal and uninhibited neurogenic bladder.
    Jensen D
    Acta Neurol Scand; 1981 Dec; 64(6):401-26. PubMed ID: 6127859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative assessment of combined therapy of neurogenic hyperactivity of detrusor in patients with Parkinson's disease].
    Loran OB; Fedorova NV; Mazurenko DA; Khitarishvili EV
    Urologiia; 2006; (2):37-9, 41. PubMed ID: 16708587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
    Madersbacher H; Mürtz G; Alloussi S; Domurath B; Henne T; Körner I; Niedeggen A; Nounla J; Pannek J; Schulte-Baukloh H; Schultz-Lampel D; Bock P; Strugala G
    BJU Int; 2009 Mar; 103(6):776-81. PubMed ID: 19007380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
    Pannek J; Göcking K; Bersch U
    BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Solifenacin in the treatment of patients with hyperactive urinary bladder].
    Al-Shukri SKh; Kuz'min IV
    Urologiia; 2007; (3):19-21. PubMed ID: 17722615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of drugs and clean intermittent catheterization in the treatment of neurogenic bladder. Effect on continence].
    Jiménez J; Arruebarrena D; Rodríguez J; Urbieta MA; Arriola M; Aresès R
    An Esp Pediatr; 1987 Nov; 27(5):343-6. PubMed ID: 3439656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural fill urodynamics and conventional cystometrogram in infants with neurogenic bladder.
    Jorgensen B; Olsen LH; Jorgensen TM
    J Urol; 2009 Apr; 181(4):1862-7; discussion 1867-8. PubMed ID: 19233391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.